Nutikka Anita, Lingwood Clifford
Research Institute, Division of Infection, Immunity, Injury and Repair, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Glycoconj J. 2004;20(1):33-8. doi: 10.1023/B:GLYC.0000016740.69726.fb.
Purified renal globotriaosyl ceramide (Gb3)/cholesterol mixtures sonicated heated in a Triton-containing buffer placed below a discontinuous sucrose gradient form glycosphingolipid (GSL)-containing dense lipid structures at the 30/5% sucrose interface after centrifugation. Inclusion of fluorescein-labeled verotoxin 1 B subunit (FITC-VT1 B) within the most dense sucrose layer results in the fluorescent labeling of this Gb3-containing raft structure. Alternatively inclusion of I-labeled VT1 fractionation allows quantitation of binding. FITC-VT1 B effectively competes for I-VT1/Gb3 raft binding. This assay will allow the definition of the optimal raft composition for VT1 (or any other ligand) binding. The effect of several potential cellular raft components are reported. Increased cholesterol content increased VT1 binding. Addition of phosphatidylethanolamine had minimal effect while phosphatidylserine was inhibitory. Although inclusion of sphingomyelin increased the Gb3 content of the "raft" reduced VT1 binding was seen. Inclusion of other glycolipids can also be inhibitory. The addition of globotetraosyl ceramide had no effect; however addition of sulfogalactosyl ceramide but not sulfogalactoglycerolipid inhibited VT1/Gb3 raft binding. These results suggest that certain GSLs can disfavor the formation of the appropriate 'raft' structure for ligand binding that this is dependent on both their carbohydrate lipid structure. Such "deceptor" GSLs may provide an as yet unappreciated mechanism for the regulation of cellular GSL receptor activity. This model is an effective tool to approach the dynamics ligand-binding specificity of GSL/cholesterol-containing lipid microdomains.
纯化的肾球三糖神经酰胺(Gb3)/胆固醇混合物在含有Triton的缓冲液中超声处理并加热,置于不连续蔗糖梯度下方,离心后在30/5%蔗糖界面形成含糖鞘脂(GSL)的致密脂质结构。在最致密的蔗糖层中加入荧光素标记的志贺毒素1 B亚基(FITC-VT1 B)会导致这种含Gb3的筏状结构产生荧光标记。或者,加入I标记的VT1进行分级分离可实现结合定量。FITC-VT1 B能有效竞争I-VT1/Gb3筏状结构的结合。该检测方法将有助于确定VT1(或任何其他配体)结合的最佳筏状结构组成。报道了几种潜在细胞筏状结构成分的作用。胆固醇含量增加会增加VT1的结合。添加磷脂酰乙醇胺影响最小,而磷脂酰丝氨酸具有抑制作用。虽然加入鞘磷脂会增加“筏”中的Gb3含量,但可见VT1结合减少。加入其他糖脂也可能具有抑制作用。添加球四糖神经酰胺没有影响;然而,添加硫酸半乳糖神经酰胺而非硫酸半乳糖甘油酯会抑制VT1/Gb3筏状结构的结合。这些结果表明,某些GSL可能不利于形成适合配体结合的“筏”结构,这取决于它们的碳水化合物和脂质结构。这种“去受体”GSL可能为调节细胞GSL受体活性提供一种尚未被认识的机制。该模型是研究含GSL/胆固醇脂质微区动力学配体结合特异性的有效工具。